Back to results
US 2003/0148961 A1Published application
Peptidyl ketones as inhibitors of DPIV
AssigneeOSI Pharmaceuticals, Inc.
InventorsUlrich Heiser, Andre Niestroj, Torsten Hoffmann, Hans-Ulrich Demuth
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of the general formula 1 1 and pharmaceutically acceptable salts thereof, to the use of the compounds for the treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidosis, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus in mammals.
Claims14
Compounds of the general formula 1
- 13
- and pharmaceutically acceptable salts thereof, wherein:
- A is selected from the following structures:
- 14
- wherein
- X1 is H or an acyl or oxycarbonyl group including an amino acid residue, a N-protected amino acid residue, a peptide residue or a N-protected peptide residue,
- X2 is H, —(CH)m—NH—C5H3N—Y with m=2-4 or —C5H3N—Y (a divalent pyridyl residue) and Y is selected from H, Br, Cl, I, N2 or CN,
- X3 is H or selected from an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted phenyl or from an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted pyridyl residue,
- X4 is H or selected from an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted phenyl or from an alkyl-, alkoxy-, halogen-, nitro-, cyano- or carboxy-substituted pyridyl residue,
- X5 is H or an alkyl, alkoxy or phenyl residue,
- X6 is H or an alkyl residue,
- for n=1
- X is selected from:
- H, OR2, SR2, NR2R3, N+R2R3R4, wherein:
- R2 stands for acyl residues, which are optionally substituted with alkyl, cycloalkyl, aryl or heteroaryl residues, or for amino acid residues or peptidic residues, or alkyl residues, which are optionally substituted with alkyl, cycloalkyl, aryl or heteroaryl residues,
- R3 stands for alkyl or acyl residues, wherein R2 and R3 may be part of a saturated or unsaturated carbocyclic or heterocyclic ring,
- R4 stands for alkyl residues, wherein R2 and R4 or R3 and R4 may be part of a saturated or unsaturated carbocyclic or heterocyclic ring,
- for n=0
- X is selected from:
- 15
- wherein
- B stands for:
- O, S or NR5, wherein R5 is H, alkyl or acyl,
- C, D, E, F, G, Y, K, L, M, Q, T, U, V and W are independently selected from alkyl and substituted alkyl residues, oxyalkyl, thioalkyl, aminoalkyl, carbonylalkyl, acyl, carbamoyl, aryl and heteroaryl residues, and
- Z is selected from H, or a branched or straight chain alkyl residue from C1-C9, a branched or straight chain alkenyl residue from C2-C9, a cycloalkyl residue from C3-C8, a cycloalkenyl residue from C5-C7, an aryl or heteroaryl residue, or a side chain selected from all side chains of all natural amino acids or derivatives thereof.
22 more elements
Dependencies are inferred from the claim text.